Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine/Erlotinib vs Gemcitabine/Erlotinib in Advanced Pancreatic Cancer
NCT00440167Phase 3Unknown
- Sponsor
- Volker Heinemann
- Start
- Jun 2006
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 3 trial of capecitabine in pancreatic cancer (PC), sponsored by Volker Heinemann. Status: unknown.
02
Drugs
capecitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00440167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440167.